Structure and Biochemistry of henipavirus polymerase complex10/31/2022 - 09/30/2025 (PI)
Bill and Melinda Gates Foundation
Studies to Assess the Mechanism of Action of an L Inhibitor02/15/2022 - 09/30/2025 (PI)
Merck, Sharp & Dohme LLC
Determining the impact of respiratory syncytial virus M2-1 protein on post-transcriptional regulation of cellular and viral mRNAs08/14/2023 - 07/31/2025 (PI)
NIH/National Institute of Allergy & Infectious Diseases1R21AI174597-01
Antiviral Countermeasures Development Center (AC/DC) //AViDD Pilot Project05/01/2023 - 04/30/2025 (Subcontract PI)
Emory University NIH NIAID1U19AI171403-01
Mechanisms of Marburg virus gene expression05/08/2018 - 04/30/2025 (Multi-PI)
PI:
Rachel Fearns, PhDNIH/National Institute of Allergy & Infectious Diseases5R01AI133486-05
Molecular characterization of virulence factors in an in vitro model of Respiratory Syncytial Virus and Streptococcus pneumoniae co-infection02/22/2024 - 02/28/2025 (Subcontract PI)
Boston Medical Center Corporation Merck, Sharp & Dohme
Modeling the permature airway with neonatal airway basal cells06/01/2022 - 05/31/2023 (Subcontract PI)
Massachusetts General Hospital NIH NIAID5R21AI156597-02
The B cell repertoire as a window into the nature and impact of the lung virome05/01/2019 - 04/30/2023 (Multi-PI)
PI:
Rachel Fearns, PhDNIH/National Heart, Lung, and Blood Institute5R33HL137081-05
Characterize the transcriptional and genome replication mechanism of paramyxoviruses for the discovery of broad spectrum anti-virals09/01/2020 - 04/16/2023 (PI)
F. Hoffmann-La Roche, Ltd.
Studies to assess the mechanism of inhibition of pneumovirus L and N-P inhibitors10/01/2020 - 01/31/2023 (PI)
Enanta Pharmaceuticals, Inc
Showing 10 of 22 results.
Show All Results
Interplay between respiratory syncytial virus and nucleotide biosynthesis pathways02/07/2020 - 01/31/2023 (PI)
NIH/National Institute of Allergy & Infectious Diseases5R21AI147659-02
Developing Combination Therapies against Pneumo- and Paramyxoviruses Causing Severe Respiratory Infection07/01/2018 - 06/30/2022 (Subcontract PI)
Georgia State University NIH NIAID5R01AI071002-15
Evaluating the mechanism of actino of RSV L inhibitors targeting the CRV region05/03/2019 - 06/04/2021 (PI)
Janssen Sciences Ireland
Initiation and regulation of RSV mRNA transcription and genome replication08/07/2014 - 07/31/2020 (PI)
NIH/National Institute of Allergy & Infectious Diseases5R01AI113321-04
Mechanism of action of an RSV N protein inhibitor04/01/2018 - 10/15/2019 (PI)
Enanta Pharmaceuticals, Inc
The B cell repertoire as a window into the nature and impact of the lung virome05/01/2017 - 04/30/2019 (Multi-PI)
PI:
Rachel Fearns, PhDNIH/National Heart, Lung, and Blood Institute5R61HL137081-02
Treating Respiratory Syncytial Virus Infection by Targeting a Virus-Associated Kinase04/01/2015 - 03/31/2019 (PI)
The Hartwell Foundation
A structure analysis of the intact viron and replicative complexes of human respiratory syncytial virus11/30/2014 - 03/31/2019 (Subcontract PI)
University Glasgow Medical Resrch Coun
Development of an in ivtro assay for paramyxovirus polymerases05/16/2014 - 11/04/2018 (PI)
Alios BioPharma, Inc.
Development of a non-radioactive assay for the RSV polymerase11/12/2015 - 11/11/2017 (PI)
Merck, Sharp & Dohme LLC
The development of respiratory syncytial virus polymerase assay and mechanism of action studies07/15/2013 - 09/30/2017 (PI)
AstraZeneca
Respiratory Syncytial Virus Polymerase Protein and Promoter Interactions09/30/2008 - 08/31/2013 (PI)
NIH/National Institute of Allergy & Infectious Diseases5R01AI074903-04